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3D cell culture stimulates the 
secretion of in vivo like extracellular 
vesicles
Sirisha Thippabhotla1, Cuncong Zhong1,2 & Mei He2,3,4
For studying cellular communications ex-vivo, a two-dimensional (2D) cell culture model is currently 
used as the “gold standard”. 2D culture models are also widely used in the study of RNA expression 
profiles from tumor cells secreted extracellular vesicles (EVs) for tumor biomarker discovery. Although 
the 2D culture system is simple and easily accessible, the culture environment is unable to represent 
in vivo extracellular matrix (ECM) microenvironment. Our study observed that 2D- culture derived 
EVs showed significantly different profiles in terms of secretion dynamics and essential signaling 
molecular contents (RNAs and DNAs), when compared to the three-dimensional (3D) culture derived 
EVs. By performing small RNA next-generation sequencing (NGS) analysis of cervical cancer cells and 
their EVs compared with cervical cancer patient plasma EV-derived small RNAs, we observed that 
3D- culture derived EV small RNAs differ from their parent cell small RNA profile which may indicate 
a specific sorting process. Most importantly, the 3D- culture derived EV small RNA profile exhibited a 
much higher similarity (~96%) to in vivo circulating EVs derived from cervical cancer patient plasma. 
However, 2D- culture derived EV small RNA profile correlated better with only their parent cells cultured 
in 2D. On the other hand, DNA sequencing analysis suggests that culture and growth conditions do 
not affect the genomic information carried by EV secretion. This work also suggests that tackling EV 
molecular alterations secreted into interstitial fluids can provide an alternative, non-invasive approach 
for investigating 3D tissue behaviors at the molecular precision. This work could serve as a foundation 
for building precise models employed in mimicking in vivo tissue system with EVs as the molecular 
indicators or transporters. Such models could be used for investigating tumor biomarkers, drug 
screening, and understanding tumor progression and metastasis.
Extracellular vesicles (EVs) are a heterogeneous mixture of membranous structures, derived from either the cel-
lular endosomal pathway or shed from the plasma membrane1. Due to the different biogenesis, EVs are gen-
erally classified as the exosomes (~30–250 nm) and microvesicles (~100–1000 nm)2–5. Microvesicles with a 
particle size up to 1 µm are formed by the outward budding from the cell membrane1,6. In contrast, exosomes 
are one subgroup of EVs formed from the intercellular structure via the inward invagination of endosome mem-
branes7, which encapsulated complex cellular signaling components, including proteins, lipids, and nucleic acids 
(e.g., mRNA, miRNA, DNA)8,9. However, the current definition of exosomes is still not well defined. Assigning 
an EV to a particular biogenesis pathway remains extraordinarily difficult. In order to be consistent with the 
International Society for Extracellular Vesicles (ISEV community), we use the generic term “extracellular vesicles 
(EVs)” while referring to small vesicles (<~250 nm)10. EVs play important roles in cell-to-cell communications 
via cross-transferring of important signaling components11–14. For instance, EVs can carry and transmit mRNAs 
and miRNAs for promoting tumor growth, which has been identified as the diagnostic biomarkers for lung can-
cer15, breast cancer16 and ovarian cancer17,18. The mRNAs found in smaller EVs (exosomes) can be transferred 
and translated to functional proteins after uptake by other cells19. The RNA content in EVs varies depending 
on the cell type and cellular status from their parent cells, for performing cell-to-cell communications20–25. The 
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mechanism of how specific RNA sequences are selectively packaged into EVs is still unknown, but is an intensive 
area of investigation3,26–28.
For investigating cellular communications and behaviors ex vivo, presently, the two-dimensional (2D) cell 
culture model is widely used as the “gold standard”29. This 2D culture system serves as an essential model for 
investigating tissue physiology and complex biological activity, from cell differentiation to tissue morphogen-
esis30. Many 2D cell culture systems have also been widely employed for studying EV RNA expression profiles 
from tumor cells31, roles in promoting tumor growth17 and tumor biomarker discovery32–34. Although the 2D 
culture system provides simple cell attachment and nutrients supply, the flat and hard surface from plastic or glass 
substrates are unable to represent the in vivo extracellular matrix (ECM) microenvironment in tissue or organs35. 
The monolayer cells under 2D culture condition completely differ from in vivo status where cells grow in three 
dimensions (3D), in terms of cell morphology, cell-to-cell interactions, growth behavior, and interactions with 
extracellular matrix30. It has been well demonstrated that 2D cell monolayer is unable to represent the physiology 
of in vivo 3D tissues or organs, due to the substantially different microenvironment (e.g., mechanical and bio-
chemical properties) in tissue architecture36–41.
Unlike the 2D culture, 3D cell culture is more recognized for mimicking in vivo cellular behavior41. Instead 
of cell-to-cell interaction only by the edge in the 2D culture system, 3D cell culture involves cellular stretch 
and interactions from all angles, as well as the cell-to-ECM interactions35. These interactions aid in promoting 
cellular signaling transduction and proliferation. For instance, the behaviors of 3D tumor spheroids are more 
clinically relevant, considering hypoxia in the drug screening research42. Skin cells under 3D culture conditions 
survive better than 2D conditions when exposed to cytotoxic agents43. The ECM serves as the scaffold which is 
critical for cell adhesion, movement, stretch, proliferation and differentiation, and the prevention of apoptosis44. 
Within the 3D culture environment, we observed that cellular EV secretion dynamics and molecular contents are 
altered, compared to the 2D- culture derived EVs. This observation indicates that 3D- culture derived EV small 
RNAs could reflect in vivo tissue-derived EV RNAs. Although studies have been performed on EV secretion from 
human plasma using a 2D culture sytem45,46, there have been no reports on the EV secretion landscape from 
3D culture and their potential for mimicking in vivo tissue system. The EV biogenesis mechanisms, molecular 
sorting, vesicle trafficking and releasing are still not well understood so far7,26. Other reports and our observation 
support that EV secretion behavior and molecular cargoes are altered by the influence of many factors including 
parent cell types, physiological and pathological status, and the stimuli from microenvironments47. Thus, only 
EVs derived from parent cells under biomimetic tissue culture conditions can reflect the in vivo EVs, which is 
extremely essential for studying cellular biological function, cell-to-cell communications and signaling transduc-
tions accurately. Such discoveries could eventually lead to the development of clinically significant EV biomarkers 
and therapeutic agents.
In this paper, we observed that 2D- culture derived EVs showed significantly different profiles in terms of 
secretion dynamics and essential signaling molecular contents (RNAs), compared to the 3D- culture derived EVs. 
By next-generation sequencing (NGS) analysis of cervical cancer cells and cervical cancer patient plasma-derived 
EV RNA, we observed that 3D- culture derived EV small RNAs may undergo specific sorting process that differs 
from their parent cells. Most importantly, the 3D- culture derived EV small RNA profile exhibited a much higher 
similarity (~96%) to in vivo circulating EVs from cervical cancer patient plasma, in comparison with 2D derived 
EV small RNA profile. On the other hand, DNA sequencing analysis suggests that culture and growth conditions 
do not affect the genomic information carried by EV secretion. By tackling EV molecular contents and alterations 
collected from interstitial fluids, we can provide an alternative, non-invasive approach for investigating 3D tissue 
behaviors at the molecular precision. This work could serve as a foundation for building precise model employed 
in mimicking in vivo tissue system, with EVs as the molecular indicators or vehicles, for investigating tumor bio-
markers, drug screening, and understanding tumor progression and metastasis.
Results
EV secretion dynamics from 3D- cultured cells significantly differ from 2D culture system. In 
order to culture in-vivo like 3D cells, we choose to use peptide hydrogel as the scaffolding material which has high 
biocompatibility and self-healing property for transforming between liquid and gelation48–50. This peptide hydro-
gel is stable in neutral pH and remains as gel formation in a wide range of temperatures from 2 °C to 80 °C51,52. 
We examined the peptide hydrogel scaffolding structures in Fig. 1A to evaluate the 3D ECM microenvironment, 
which shows the dense mesh network with pore size nearly around 500 nm. The flexible mechanical tensile of 
peptide gel allows cells to proliferate and expand as a 3D spheroid. Due to the high biocompatibility, the big 3D 
spheroid still can attach well with the scaffolding support. We observed four classic morphologies presented in the 
3D cultured spheroids with peptide hydrogel scaffolds: round, mass, grape, and stella, as shown in Fig. 1B, which 
is consistent with the literature report53,54. Confocal fluorescence image was further used to confirm the round 
tumor-like morphology in Fig. 1C, which exhibits the typical in vivo tumor-like tissue architecture55 with each 
round cells laid over to form tumor spheroid. Figure 1C is a 3D confocal imaging reconstruction of cervical tumor 
cell spheroid using our 3D culture method. The heat map encoded red to blue color is to display the z-dimension 
change (height of tumor spheroid) which can give a better visualization of tumor cell distribution in the spheroid. 
The cervical cancer HeLa cells formed round spheroids after 4–5 days culture which are the most typical tumor 
morphology dominated in our 3D culture system. The grape and stellate shapes were observed occasionally. In 
strong contrast, 2D cultured HeLa cells are in the flat spreading and attached to the bottom of the culture plate, 
which is substantially lacking cell-to-cell contact, as shown in Fig. 1D. Even though in the high-density culture 
condition, the cell contacts in 2D are only through the cell edges with much loose communication.
We further examined the EV secretion rate by using nanoparticle tracking analysis (NTA) to monitor the 
EVs derived from both 2D culture and 3D culture systems under different culture durations. For 3D cells, the 
culture can reach 90% confluence after 11 days which is much slower than 2D culture system. So we followed the 
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comparable cellular growth status to collect EVs. For 2D- cultured cells, we harvest EVs from media in 6 h, 12 h, 
24 h, 36 h, and 48 h intervals, while 3D culture derived EVs are harvested at day 5, 7, 9, 11, and 13, individually. 
The live cells were counted at each time interval for establishing the calibration curve of 3D cell confluency behav-
ior (Fig. s2). The EV secretion rate from the 3D- cultured cells is more active when cells approach the confluency, 
which is reflected by three times more EVs secreted after day 9. In contrast, 2D- cultured cells reduce the EV 
secretion and undergo a declining trend, which may attribute to the reduced cell-to-cell contact and communica-
tion. The harvested EVs showed typical round, cup shape via SEM imaging in both 2D and 3D culture conditions 
(Fig. 2B,D), while 3D- culture derived EVs showed the more dense distribution of smaller size. These obser-
vations were in agreement with Rocha, et al. that exosomes released by tissue-engineered tumors were smaller 
than exosomes released by the same cells cultured in monolayer, and the 3D system is more active for producing 
exosomes56,57. It is interesting that our observation is the same as Rocha, et al. report that the maximum period for 
conditioned media collection was 48 h for 2D. Rocha, et al. also observed that in 3D this period could be extended 
for another 4 d without compromising cell viability56. We characterized the confluency property for both 2D and 
3D cultures (see Fig. s2). For reaching to the same confluency as a 2D system (~90%), our HeLa cells in the 3D 
system require 11 days. However, after 11 days, we observed decreased secretion of EVs at day 13 which may due 
to the reduced cell viability. Generally, after 90% confluency, cells are required to do subculture to provide more 
growing space. This observation could still be speculating and more longer-term study will need to give a defin-
itive conclusion. The number of cells used in 3D cultures for producing EVs is considerably lower than that in 
2D (seeding density: 3D ~8 × 104 vs. 2D ~5 × 105). At the end- point of harvesting, 3D cells are ~9-fold less than 
2D cells. The increased secretion of EVs in the 3D system together with Rocha, et al.and other observations56,58 
strengthened the efficiency of the 3D system which could be more useful and accurate for EV functional studies 
mimicking the in vivo physiological environment.
The 3D- cell culture derived EV RNA profile shows a significantly high similarity to in vivo EV 
RNA profile. In order to investigate the EV RNA profiles which are altered under different culture condi-
tions with their parent cells, we prepared multiple EV RNA extracts as analyzed in Fig. 3 by Agilent Bioanalyzer, 
including EV RNAs derived from 2D culture, 3D culture, and cervical cancer patient plasma, compared with 
parent cell RNAs in 2D and 3D culture conditions. We study two cervical cancer patient plasma samples and one 
healthy individual plasma sample for comparison with 3D- culture derived EVs, because circulating extracellular 
vesicles and exosomes now are recognized as promising tumor surrogates59–65. Circulating EVs can be collected 
noninvasively with highly increased abundance in cancer patient plasma64. Additionally, EVs are relatively stable 
over time and include proteins and nucleic acids from their parental tumors66. Thus, cancer patient plasma could 
serve as a reference for in vivo tumors67,68.
The EV isolation and RNA extraction steps are illustrated in SI Fig. s1 and detailed in the experimental section 
for both cell culture media and human plasma. In contrast to their parent HeLa cell-derived RNAs which are 
mainly in the long size range (2000–4000 nucleotides), EVs carry more small RNAs around the range below 200 
nucleotides. Several studies have shown that EVs carry small coding and noncoding RNAs used by their parent 
cells as an intercellular network of communication69–72. It has been proposed that a selective packaging process 
for loading RNAs into EVs shedding into extracellular microenvironment which could modify the phenotype of 
the recipient cells, although the mechanisms underlying are still largely unknown26,27. Parent cells take up solutes, 
nutrients, and ligands from the extracellular environment via the multiple endocytic pathways and traffic via early 
endosomes26. From endosome maturation into late endosomes, inward budding from the limiting membrane of 
the endosome leads to the formation of multi-vesicular bodies (MVBs) containing intraluminal vesicles (ILVs), 
and then fuse with the plasma membrane to release their ILVs into the extracellular space as exosome EVs26. 
Figure 1. (A) The SEM images showing the morphology of peptide hydrogel as the scaffolds (top, the scale bar 
is 5μm) for the 3D culture of cervical cancer HeLa cells (bottom, the scale bar is 50 μm). (B) The four typical 3D 
HeLa cellular morphologies (round, mass, grape, and stella) observed under the bright-field microscopy. The 
scale bar is 50 μm. (C) The fluorescence confocal microscopic image showing the 3D HeLa tumor-like growth. 
The 3D confocal image was reconstructed with density distribution using heat map and the depth is 60 μm. (D) 
The 2D cultured cellular morphology in flat spreading with both low density and high-density seeding, which 
was observed under the bright-field microscopy. The scale bar is 20 μm.
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During MVB formation, cytosolic RNAs are taken up into ILVs undergoing inward budding with a selective 
lipid-mediated loading of RNA into EVs28. A few RNA-binding proteins have been found capable to selectively 
bind RNA molecules with specific motifs and induce their export into EVs, such as hnRNPA2B126,73. In this study, 
we also can observe a significant amount of small regulatory RNAs enriched in EVs, but not significant in their 
parent HeLa cells, regardless of 2D or 3D culture conditions. As seen in Fig. 3, parent cell-derived RNAs contain 
a large number of ribosome RNAs in the range of 2000–6000 nucleotides, such as the 16s and 18s. Because the 
HeLa cell line is the established cell line from the cervical cancer patient, we further compared the EV RNA 
extract from the cervical cancer patient plasma which also are mainly small coding and non-coding RNAs.
For further understanding the landscape of EV RNA compositions under different culture conditions of their 
parent cells, and providing an accurate profile of the different coding and non-coding RNA species found per cul-
ture compartment, we did small RNAs library preparation (<200 nt) and used the next- generation sequencing to 
characterize EV derived RNAs and parent cell RNAs in depth. We generated small RNA libraries from EVs, their 
donor cells, and corresponding cervical cancer patient plasma samples using NEXTflex small RNA sequencing 
kit with size selection. The characterization of the small RNA content of EVs is still not well established in this 
research field and we did substantial optimization work on EV isolation quality control using NTA and SEM/
TEM imaging. We also performed the biological replicates for 2D cell RNAs, 3D cell RNAs, and cervical cancer 
patient plasma EV RNAs. The consistent results between biological replicates indicate that our protocols and 
results are valid. Thus, the other two biological samples (2D exo-RNAs, 3D exo-RNAs) with one input were 
considered to be sufficient for all described comparisons. We also used quantitative real-time PCR (qPCR) to 
validate the NGS results. The resulting reads were aligned to the RefSeq transcriptome annotation (version hg38, 
downloaded from the UCSC genome browser), the GENCODE (version 28 for hg38), tRNA annotation tracks 
(version hg38, downloaded from the UCSC genome browser), and the miRNA annotations tracks (version hg38, 
downloaded from sRNAnalyzer database), using BWA74. Only the uniquely aligned reads were considered for 
downstream analysis. A significant portion (>90%) of the reads were mapped as mRNAs while a much smaller 
fraction of the reads was mapped as other non-coding RNAs, as shown in Fig. 4. This finding is consistent with 
other reported research that EVs may transport largely mRNA fragments to recipient cells75,76, which may indi-
cate a novel mechanism along with miRNAs for genetic exchange between cells19. It is worth mentioning that EV 
miRNA contents from cervical cancer patient plasma are clearly higher than the healthy individual (3:1), which 
is consistent with majority reports that miRNAs were significantly enriched in EVs as the important diagnostic 
markers for cancer77–79.
The next-generation RNA-Seq profiling of EV miRNAs from biopsy specimens is a relatively underexplored 
frontier. To compare the EV miRNA content derived from various samples, the top 100 miRNAs with the highest 
Figure 2. The nanoparticle tracking analysis (NTA) of EV secretion rate between 2D culture (A) and 3D culture 
(C) systems. The live- cell counting was performed at each time interval with three replicated cultures. The 
statistic CV is ~3–10%. The harvested EVs from 2D (B) and 3D (D) culture conditions showed typical round, 
cup-shaped EVs around 100 nm size via SEM imaging (Insert). The size distribution and abundance were 
measured using NTA with five replicated measurements. The statistic CV is ~5%.
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Figure 3. Bioanalyzer analysis of EV RNAs derived from 2D culture, 3D culture, and cervical cancer patient 
plasma, compared with parent cell RNAs in 2D and 3D culture conditions.
Figure 4. Graph depicting the percentage of reads mapped to transcriptomic regions. The majority of the 
sequences (>90%) belonged to the protein coding region (mRNA’s) of the transcriptome. The remaining 
fraction was mapping to the non-coding regions of the transcriptome. Mapping sequences from 2D and 3D cell 
culture, EVs from 2D and 3D cultures, EVs from cervical cancer patient plasma and EVs from healthy patient 
plasma cultures were used for analysis. 1 and 2 annotate the two biological replicates.
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average abundances in all samples were selected, and their abundance profiles were subsequently clustered (see 
Fig. 5). EV-derived miRNAs showed significantly different expression profile than their parent cells in both 2D 
and 3D conditions. However, their parent cells cultured between 2D and 3D systems exhibited similar miRNA 
expression profile. Rocha, et al.56 also observed that striking differences between small RNAs detected in EVs and 
in donor cells, which support our results and other research reports indicating a specific sorting process of small 
RNAs into EVs26,27. As anticipated, replicates (2D-cell miRNAs and 3D-cell miRNAs) were clustered together. It 
is interesting that we observed the significant difference of miRNAs expression profile between 2D and 3D culture 
derived EVs, while Rocha, et al. showed high similarity56. The experimental data explaining this phenomenon 
are still scarce, and more investigation should be performed for a definitive conclusion. More importantly, we 
observed that 3D cell-derived EV sample was clustered together with two in vivo cervical cancer patient plasma 
sample derived EV miRNAs. It supports that 3D cell culture is necessary for reproducing the EV miRNA con-
tent sorted by in vivo cells and establishing an accurate disease model57,58. On the other hand, the 2D-derived 
samples were clustered away from the in vivo samples, indicating that 2D cell culture was unable to represent 
Figure 5. Heatmap with dendrogram depicting top 100 highly expressed miRNAs in 2D Cell, 3D Cell, and 
their derived EV miRNAs in relation to cervical cancer patient plasma EV miRNAs and healthy plasma EV 
miRNAs. Red color indicates a higher expression z-score. Hierarchical clustering was performed, using the 
Spearman correlation method. 3D culture derived EVmiRNA profile and Cervical cancer patient plasma EV 
miRNA profile have been clustered together due to higher similarities in their transcript expressions. 1 and 2 
annotate the two biological replicates.
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in vivo biological status. This observation supports the statement from other studies56,58 that 3D culture system 
would be more useful and accurate for mimicking in vivo physiological environment in studying EV functions. 
It is interesting that multiple miRNAs were discovered to be present in 3D cell-derived EVs as well as the cervical 
cancer patient plasma-derived EVs, but not in 2D- culture derived EVs. A few of these miRNAs, such as miRNA- 
2277, miRNA-3691, miRNA-4488, miRNA- 548ao, miRNA-6871, miRNA-93, miRNA-4763, miRNA-6751, and 
miRNA- 4633–5p, have been highly associated with control of stability and translation of mRNA80–82. To explore 
the miRNA pathways significantly enriched in EVs from their parent cells, we performed an over-representation 
analysis (ORA) of two groups of miRNAs with a fold change threshold of 10 (i.e. Log of fold change >10). The 
results were presented in supplementary information Tables s1 and s2. The top pathways with 10-fold change 
or above are mostly associated with metabolism pathway, transport and translation of proteins, and remained 
similar between EVs and their parents without the influence of culture conditions (2D exo miRNAs vs. 2D cell 
miRNAs, 3D exo miRNAs vs. 3D cell miRNAs).
We further performed region-based annotation on the EV RNA reads, using ANNOVAR74. Most of the reads 
(~90%) belonged to the Intronic, Intergenic, Upstream and UTR5 regions, and their distributions are shown in 
Fig. 6. The remaining reads (10–12%) were mapped to other whole genomic regions (Exonic, Splicing, UTR3, 
Downstream). The results again showed the significant similarity between the 3D cell-derived EV RNAs and 
in vivo cervical cancer patient plasma-derived EV RNAs, reconfirming the advantage of using 3D cell culture 
system.
In order to validate the RNA-Seq data and prove the viability of results, we selected six miRNAs from pre-
viously samples submitted to RNA-Seq (Hsa-miR-125b-1-3p, Hsa-miR-208a-5p, Hsa-miR-450b-3p, Hsa-miR-
1229-3p, Hsa-miR-1284, Hsa-miR-1909-3p) for quantitative real-time PCR validation (Fig. s3 and Fig. 7). The 
Figure 6. Bar graph depicting the percentage of reads mapped to whole genome regions. The majority of 
the sequences belong to Intronic, Intergenic, Upstream and UTR5 regions of the whole genome nucleotide 
sequences. Comparisons were made with nucleotide sequences derived from cervical and healthy patient 
plasma EVs, 2D cell, 2D EVs, 3D cell, and 3D EVs. 1 and 2 annotate the two biological replicates.
Figure 7. Box-plots depict the correlation between real-time PCR (qPCR) and small RNA Next Generation 
Sequencing (NGS), for six differentially expressed miRNA genes. Log2-fold changes calculated for both real- 
time qPCR (green and blue boxes) and NGS (green and blue circles) analysis are reported. The lines inside the 
boxes denote the medians. The boxes mark the interval between the 25th and 75th percentiles with SD as the 
error bars.
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selected 6 miRNAs must be expressed in all samples (FPKM >0), with a good sample detection (FPKM >10,000). 
We compared expression level fold change between 3D EVs vs. 2D EVs, and 3D cells vs. 2D cells as shown in 
the Fig. 7. In the cellular system, the expression levels of the six miRNAs mostly are correlated with the data 
obtained by NGS in terms of the trends of down-regulation or up-regulation, especially for Hsa-miR-125b-1-3p, 
Hsa-miR-450b-3p, and Hsa-miR-1909-3p which are all upregulated in the similar fold change (~1.5 fold) from 
both PCR and NGS analysis in 3D culture system. Those three miRNAs are reported to be associated with regulat-
ing tumor growth83–85. For the EV RNAs data, those three miRNAs (Hsa-miR-125b-1-3p, Hsa-miR-450b-3p, and 
Hsa-miR-1909-3p) are also correlated very well between PCR and NGS analysis, with much higher fold change 
(~2–5 fold) in the 3D system. Overall, in the EVs system, the fold change levels are higher than that in the cellular 
system, which may indicate 3D- culture derived EV system carries more enriched miRNAs involved with cellular 
functional regulation. No matter 2D culture or 3D culture, among those six miRNAs, Hsa-miR-208a-5p did not 
show much significant expression level fold change in both EVs system and cellular system under the analysis 
of both PCR and RNA-Seq. The Hsa-miR-208a-5p is mostly involved in post-transcriptional regulation of gene 
expression by affecting the stability and translation of mRNAs, which may not be influenced influcenced under 
different culture conditions. We observed a strong correlation between the quantitative real-time PCR results and 
the small RNA sequencing data in both cellular RNAs and EV RNAs, and 3D samples showed higher expression 
levels of the selected miRNAs. This observation also validates our NGS methods for investigating 3D culture 
system employed in mimicking in vivo tissue system and producing extracellular vesicles.
The 3D- cell culture derived EV DNA profiling. We also performed the extraction of EV DNA for ana-
lyzing DNA sequences between different cultures of their parent cell. To ensure the quality of extracted EV DNAs 
without the interference of cell free-DNAs and RNAs, we optimized the extraction protocols using the combina-
tion of the QIAamp DNA Mini Kit and the exoRNeasy Serum/Plasma Starter Kit with adding both DNase and 
RNase sequentially (see the experimental section for details). The quality of extracted EV DNA was assessed by 
Agilent ChipStation is shown in Figure A. Most of the DNA fragments are from genomic DNAs and smaller than 
1000 nucleotides. Highly correlated DNA fragment length distributions of the 2D and 3D culturing methods were 
observed. The reads were mapped to the reference genomes obtained from RefSeq (version hg38), using BWA 
aligner. The Spearman correlation of the protein-coding gene abundances between samples was calculated and 
shown in Fig. 8B. The results reaffirm that all samples have high abundance correlation, showing that the EV DNA 
content is more stable than the RNA content, and appears recalcitrant to various culturing methods.
For the DNA reads that were not mapped as protein-coding genes, we further predict their mapped regions 
(peaks) using HOMER method74. Similar to the protein-coding abundance profile, the predicted peaks also show 
high abundance correlation between the 2D and 3D samples. Based on the above observations, the culture and 
growth conditions do not affect the genomic information carried by EV secretion. The recent report86 also dis-
covered that serum-derived EV dsDNA was highly consistent with the paired tumor genome, which is essential 
evidence that EV DNA can be used as a genetic marker for cancer diagnosis via screening gene mutations.
Discussion
EVs are important non-contact cellular communication pathways for horizontally transferring genetic informa-
tion. Intensive studies have been devoted to this research field in recent five years showing that EV miRNAs play 
an important role in disease progression, angiogenesis, and cancer metastasis87,88. The sequencing approaches 
for studying EV RNAs and DNAs have been a spotlight and not well established in recent two years. However, 
Figure 8. (A) Quality analysis of extracted EV DNAs derived from 2D culture (top) and 3D culture (bottom). 
(B) The correlation matrix of the DNAseq reads from two biological replicates of 2D and 3D EV DNA samples 
using the Spearman correlation coefficient. The two biological replicates are exactly consistent with 100% 
correlation. The 2D and 3D EV DNAs are also highly correlated with similarity coefficient >95% (2D EV-DNA 
or 3D EV-DNA). 1 and 2 annotate the two biological replicates.
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using the right sample sources and cellular model systems are very critical. We observed that EV-derived miRNAs 
showed significantly different expression profile than their parent cells in both 2D and 3D conditions. However, 
their parent cells cultured between 2D and 3D systems exhibited similar miRNA expression profile. More impor-
tantly, we observed that 3D cell-derived EV sample was clustered together with two in vivo cervical cancer patient 
plasma sample derived EV miRNAs. Our study by comparing the secretion dynamics of EVs between 2D culture 
and 3D culture systems proved that EVs produced in the 3D culture environment may be closer to those pro-
duced by patient tumors, which is consistent with recent reports56,58. Thus, 3D culture system may constitute a 
more useful model for mimicking in vivo physiological environment in studying EV production and functions. 
For accurately understanding the real cellular communication in a biological system, the in vivo and real-time 
collected EVs can better reflect the cellular-level communications. However, obtaining human in vivo samples 
are always challenging due to limited access and regulatory issues. Therefore, building the ex-vivo cellular model 
is absolutely needed. The 3D culture protocols established in our lab using peptide hydrogel could produce cells 
with the secretion of in-vivo like EVs. This discovery also can lead to a viable and non-destructive approach for 
studying tissues and organs via collecting EVs from interstitial fluids or culture medium.
The cellular secretion of EVs is a dynamic process and reflects the microenvironmental changes or parent 
cell stress. EVs carry miRNAs which can be taken up by neighboring or distant cells for modulating recipient 
cells. Our observation and other reports26,27 both indicated that miRNA profiles of EVs differ from those of the 
parent cells, which may due to an active sorting mechanism of EV miRNAs, though this mechanism is still under 
intensive investigations26,27. Our study compared the EV RNAs derived from 2D culture and 3D culture of cervi-
cal cancer cells, in relation to human plasma EV RNAs from cervical cancer patients. This result is the evidence 
showing that nearly ~96% similarity exists between 3D- culture derived EV miRNAs and cervical cancer patient 
plasma-derived EV miRNAs. The region-based annotation on the EV RNA reads also showed that most of the 
reads (~90%) belonged to the Intronic, Intergenic, Upstream and UTR5 regions from the 3D- culture derived EVs 
are expressed at the same level as the cervical cancer patient plasma-derived EV miRNAs. On the contrary, 2D- 
culture derived EV miRNAs does not correlate as highly with human plasma EV RNA profile (~80%). Our study 
in this paper indicates that culture conditions could induce the EV RNA change, especially for miRNAs which 
have been well recognized as the crucial cancer diagnostic biomarkers89,90. By analysis of EV DNA sequenc-
ing data, we observed that culture or growth conditions do not affect the genomic information carried by EV 
secretion, which is supported by recent reports which used EV DNA as their parent tumor surrogate for cancer 
diagnosis91,92.
We also identified various microRNAs that were common to the 3D- culture derived EVs and cervical cancer 
plasma-derived EVs, indicating a much higher similarity of the 3D- culture derived EVs with the cervical cancer 
plasma-derived EVs, compared to 2D- culture derived EVs. These common microRNAs have been shown to be 
associated with the stability and translation of mRNAs. We plan to submit the RNAs that were identified in our 
experiments to widely used EV databases like ExoCarta(www.exocarta.org) which is a manually curated database 
of EV proteins, RNA and lipids. Such databases are excellent sources to obtain information about EV microRNAs, 
proteins and mRNAs, as provided by other researchers in the field.
Overall, our study focused on establishing a robust 3D cellular system allowing efficient EV production under 
controlled conditions and mimicking in vivo physiological environment for producing in vivo like EVs, in com-
parison with conventional 2D cultures. The observation supports our hypothesis that release biogenesis and 
molecular contents from EVs are very sentitive to the cellular culture environment, which could be an essential 
evaluation matrix for building biomimetic tissue accurately and employed in drug screening.
Methods
2D and 3D cell culture. Hela cells (ATCC® CCL-2™) were maintained by MEM complete medium 
(L-glucose MEM medium, Gibco, 11095072) with 10% (v/v) exosome-depleted fetal bovine serum (Gibco, 
A2720801) at 37 °C with 5% CO2. The flask was treated with Poly-D-Lysine Hydrobromide (MP Biomedicals) for 
reducing variations from substrate interaction. The 1:5 ratio of resuspended cells were taken to a new flask and 
maintained the culture until the next subculture. To subculture the cell, the cells were digested by 0.25% trypsin 
(Gibco, 25200-056) and resuspend by fresh MEM medium when the confluence reached to 90%. The culture steps 
are detailed in IS Fig. s1, and the confluence characterization for 2D and 3D culture is described in SI and Fig. s2. 
The 3D culture process was carried out by using the commercial PGmatrix DMEM Kit (PepGel LLC, PGD-006) 
per vendor’s protocol. Hela cells from the same batch of 2D culture were seeded into the peptide hydrogel with 
density ~×104 which was measured by an automated cell counter (Millipore Corporation, PHCC3000). The 3D 
culture was maintained using a 24-well cell culture plate with ~390 µL cell suspension, 10 µL PGworks solution, 
and 100 µL PGmatrix solution. The mixture was mixed by pipetting up and down carefully without introduc-
ing any bubbles. The well plate was placed into the 37 °C incubators for 1 h. After gelation, 1000 µL warmed 
fresh MEM complete medium with 10% (v/v) exosome-depleted fetal bovine serum was added to the top of 
the gel without disturbing. The medium exchange was performed every two days for supplying fresh nutrition 
and preventing drying out of hydrogel due to long-term culture. The ZOETM Fluorescent Cell Imager (Bio-Rad 
Laboratories) was used to observe growth behavior with multiple time intervals.
Human plasma samples. We used the existing sample resources from the University of Kansas Medical 
Center/Cancer Center Biospecimen repository which is a public biobank repository, and the data that include 
individually identifiable private information has not been collected specifically for this work, neither the involve-
ment of human subject. All sample collection methods were carried out in accordance with relevant guidelines 
and regulations, and there are no specific protocols approval needed.
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EV isolation and NTA analysis. EV isolation steps are illustrated in SI Fig. s1. For collecting 2D cultured 
medium used to characterize EV secretion dynamics, several time intervals were performed according to the 
confluence behavior (90% confluence in 48 hrs): 6, 12, 24, 36, 48, and 60 hours post subculture. To remove the 
cell debris, the medium was centrifuged at 3,000 g for 15 mins within 4 °C. To collect the supernatant carefully 
ready for EV isolation, the supernatant was spined at 10,000 g for 20 mins, and the debris at the bottom was dis-
carded. For collecting 3D cultured medium used to characterize EV secretion dynamics, below time intervals 
were performed according to the 3D cell confluence behavior (90% confluency in 11 days): 5, 7, 9, 11, 13 days post 
subculture. For recovering 3D spheroids, the scaffolding hydrogels were broken mechanically by pipetting up and 
down, and then transferred into a 15 mL tube for centrifuging at 600 g for 10 min at room temperature for collect-
ing cell pellet. ~0.5 mL 0.25% trypsin (Gibco, 25200-056) was added into the pellet, resuspended gently, and then 
incubated at 37 °C for 5 min. The trypsin digestion was stopped by adding 0.5 mL MEM complete medium, and 
the cell pellet was ready for use. For collecting 3D culture derived medium, after breaking scaffolding hydrogels 
by pipetting up and down, the entire solution was vortexed for 2 minutes and transferred into a 15 mL tube for 
centrifuging at 600 g for 10 min at room temperature. The supernatant was collected carefully for EV isolation. 
We use centrifugation protocols developed in our lab to collect EVs-containing supernatant detailed in SI Fig. s1. 
The collected supernatants were subject to a filtration process developed in our lab. The 0.22 µm filter (Millipore 
Express PLUS (PES) membrane) was conditioned with 10% (v/v) exosome-depleted fetal bovine serum for 2 min-
utes, then introduce prepared supernatants for filtration. The 10% exo-depleted FBS conditioning could reduce 
the trap of small EVs when filtration. We did compare the EV particle numbers before and after filtration using 
NTA analysis and did not see much difference, which is also consistent with the reported filtration method for 
ensuring the purity of smaller EVs93. Afterward, we combine Qiagen ExoRNeasy kit which contains exoEasy spin 
filtration column. The exoEasy spin column was used for spinning at 500 g for 1 min. The flow-through medium 
was discarded and spin again for 1 min at 3,200 g. ~10 mL XWP buffer was added to the column and spin for 
10 min at 3,200 g to wash the trapped exosomes in the membrane of the spin column for following downstream 
RNA or DNA extraction.
For Nanoparticle Tracking Analysis (NTA), the 2D and 3D media collected at different time intervals follow 
above-mentioned centrifugation and filtration steps for collecting isolated EVs. The collected solution was used 
to measure the particle concentration and size distribution using NanoSight LM10 (Malvern Instruments) with 
standard calibration following the vendor’s instruction.
EV RNA extraction. The culture media from the 2D and 3D cultures were harvested when the confluence 
reached ~90% (confluence characterization was shown in Fig. s2). Based on the log phase of growth of 3D cells, 
exosomes were harvested after 11 days of a subculture which is comparable to the confluence as the 2D culture. 
The medium was prepared for EV isolation based on protocols mentioned above, as well as description in SI 
Fig. s1. The exosomal RNAs were extracted using the exoRNeasy Serum/Plasma Starter Kit (Qiagen, 77023) 
following the vendor’s instruction. The kit comprises two phases: exosome purification and RNA isolation. The 
kit uses a spin column format and specialized buffers to purify EVs. Total RNA is then extracted using QIAGEN 
miRNeasy technology. In the exosome purification stage, above pre-processed medium or human plasma is 
mixed with Buffer XBP and bound to an exoEasy membrane affinity spin column. The bound exosomes are 
washed with Buffer XWP, and then lysed with QIAzol. In the RNA extraction step, chloroform is added to the 
QIAzol eluate, and the aqueous phase is recovered and mixed with ethanol. Total RNA, including miRNA, binds 
to the spin column, where it is washed three times and eluted. The Agilent Bioanalyzer 2100 Small RNA Chip 
(Agilent Technologies) was used to determine the quality of the exosomal RNA following the vendor’s instruction 
by adding 2 μL of extract into Bioanalyzer Chip.
EV DNA extraction. The EV DNAs were extracted by the combination of the QIAamp DNA Mini Kit 
(Qiagen, 51304) and the exoRNeasy Serum/Plasma Starter Kit (Qiagen, 77023) following the vendor’s instruc-
tion. ~4 mL cell culture media were used to purify EVs. The exoEasy spin column was used for spinning at 500 g 
for 1 min. The flow-through medium was recycled and spin again for 1 min at 3,200 g. ~10 mL XWP buffer was 
added to the column and spin for 10 min at 3,200 g to wash the trapped EVs on the membrane of the spin column. 
The QIAamp DNA Mini Kit was used to extract the EV DNAs. ~400 µL PBS buffer, 40 µL QIAGEN Protease, and 
4 µL RNase (Qiagen, 19101) were mixed into one 1.5 microcentrifuge tube and transferred into the center of the 
column membrane for wetting the membrane. ~400 µL AL buffer was added to the membrane slowly and mixed 
by pipette up and down without touching the membrane. The resulted column was incubated for 10 min at 56 °C, 
and then spin for 10 min at 3,200 g to collect the flow-through lysate into a new 1.5 mL microcentrifuge tube. 
~400 µL ethanol was added to the lysate and mixed for 15 s. The QIAmp Mini spin column was used for spinning 
at 6,000 g for 1 minute. Then the column membrane was washed with 500 µL AW1 buffer and AW2 buffer sepa-
rately provided in the kit. The DNA concentration was measured by Qubit® 3.0 Fluorometer (Life Technologies, 
Q33216).
Sequencing and data analysis. The RNA library was prepared by using the commercial library prepa-
ration kit NEXTflex small RNA sequencing kit (Bioo Scientific, NOVA-5132-05) following the recommended 
protocol by the manufactures. About ~20 ng input quantities was used with this kit. PAGE-based size selection 
is used for handling total extracted RNAs for 25 cycles of PCR. The Next-generation sequencing libraries for 
extracted EV DNAs was prepared using Illumina Nextera XT DNA Library Preparation Kit. The DNA peaks 
with 150 bp were purified by the gel size selection approach and eluted in ~8 µL elution buffer. The Both amplified 
libraries (RNAs and DNAs) were examined by the TapeStation gel (Angilent 2200) and quantified by Qubit® 
3.0 Fluorometer. The sequencing was performed by the KU Genomic Core using the Illumina HiSeq. 2500 
System with about ~3 million reads per sample. Raw reads were trimmed to remove the 3’ adaptor sequences. 
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The sequences were filtered by removing sequences with lengths <16 nt. The filtered sequences and quantified 
by were mapped onto the RefSeq transcriptome annotation (version hg38, downloaded from the UCSC genome 
browser), GENCODE (version 28 for hg38), tRNA annotation tracks (version hg38, downloaded from the UCSC 
genome browser), and the miRNA annotations tracks (version hg38, downloaded from sRNAnalyzer database). 
The RefSeq whole genome annotation was used to perform region-based annotation. Mapping was performed 
using BWA Aligner. Only a single optimal hit was retrieved, by setting the parameter R = 1, during alignment. 
Differences in seed length were disallowed (set k = 0). All other parameters were set to default. A comparison 
between the percentage of reads mapped using a single hit parameter (R = 1) and the default parameter, which 
allows multiple hits (R = 30) is shown in Table 1. It was observed that the mapping percentages were higher when 
multiple hits were allowed, as opposed to a single best hit. However, since the sample sequences used were very 
short (<100 bps), the sub-optimal hits obtained were most likely to be false- positive alignments, thereby making 
them unsuitable for our analysis purposes.
Quantitative real-time PCR: For validating small RNA sequencing data and prove the viability 
of the results. TaqMan Advanced microRNA assays (Thermo Fisher Scientific) were used to quantify specific 
microRNAs from parent cells and derived EV RNA samples, on a 7500 Fast Real-Time PCR system (Thermo 
Fisher Scientific). The samples previously submitted to small RNA sequencing were used and we selected 6 small 
RNAs that must be expressed in all samples (FPKM > 0), with a good sample detection (FPKM > 10,000), and 
compared the fold change between two groups of samples. Briefly, 100 ng of RNA was reversed transcribed using 
universal RT primers and the TaqMan Advanced microRNA cDNA Synthesis Kit (Thermo Fisher Scientific), 
according to vendor’s instructions. Afterward, real-time PCR was performed for each sample using 10 μL of 
diluted cDNA, TaqMan Advanced microRNA assays, and TaqMan Fast Advanced Master Mix (Thermo Fisher 
Scientific). Reactions were done with four repeats and data were analyzed by the comparative 2ΔCT method, 
where ΔCT = C(t)miRNA 3D cells − C(t)miRNA 2D cells or ΔCT = C(t)miRNA 3D EVs − C(t)miRNA 2D EVs. 
Results were represented as mean ± standard deviation. The detailed microRNA assays and PCR analysis were 
shown in Fig. s3 in the Supplemental Information.
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